A new study found that the current level of evidence does not support guidelines restricting saturated fatty acid consumption to reduce coronary risk nor does it support high consumption of polyunsaturated fats - such as omega 3 or omega 6 - to reduce coronary heart disease.
An international research collaboration led by the University of Cambridge analysed existing cohort studies and randomised trials on coronary risk and fatty acid intake.
When specific fatty acid subtypes (such as different types of omega 3) were examined, the effects of the fatty acids on cardiovascular risk varied even within the same broad 'family' - questioning the existing dietary guidelines that focus principally on the total amount of fat from saturated or unsaturated rather than the food sources of the fatty acid.
These are interesting results that potentially stimulate new lines of scientific enquiry and encourage careful reappraisal of our current nutritional guidelines, said Dr Rajiv Chowdhury, lead author of the research.
Also Read
The researchers analysed data from 72 unique studies with over 600,000 participants from 18 nations.
They found that total saturated fatty acid, whether measured in the diet or in the bloodstream as a bio-marker, was not associated with coronary disease risk in the studies.
Similarly, when analysing the studies that involved assessments of the consumption of total monounsaturated fatty acids, long-chain omega-3 and omega-6 polyunsaturated fatty acids, there were no significant associations between consumption and cardiovascular risk.
The study was published in the journal Annals of Internal Medicine.